In response to the unfortunate deaths of at least 141 children globally linked to cough syrups, the Drug Controller General of India (DCGI) has implemented a ban on the use of a combination of..
Five such companies which have firmed up their initial public offering (IPO) plans are Glenmark Lifesciences, a fully-owned arm of Glenmark Pharmaceuticals, the city-based bulk drugs firm Supriya.. Zee News - Published
Active pharmaceutical ingredient manufacturer Glenmark Life Sciences' Rs 1,514 crore ($203.65 million) initial public offering is now open for subscription. The issue, with a price band of Rs 695-720 a.. IndiaTimes - Published
Glenmark Life Sciences is a subsidiary of Glenmark Pharmaceuticals. The company is a leading developer and manufacturer of select high value, non-commoditised active pharmaceutical ingredients (APIs).. Zee News - Published
![Indian government bans Common Cold and Flu Syrups for kids below 4 years | Oneindia News [Video]](https://video.newsserve.net/300/v/20231221/1362498000-Indian-government-bans-Common-Cold-and-Flu-Syrups.jpg)
